by admin | Jul 5, 2023 | News & Opinions
By Stem Cells Translational Medicine READ THE JUNE ISSUE Human Clinical Article Cell-Based Drug Development, Screening, and Toxicology Enabling Technologies for Cell-Based Clinical Translations Manufacturing for Regenerative Medicine and more…. Click Here to...
by admin | Jul 3, 2023 | News & Opinions
By BlueRock Therapeutics Berlin, Germany and Cambridge, M.A., U.S.A., June 28, 2023 – Bayer AG and BlueRock Therapeutics LP, a clinical stage cell therapy company and wholly owned independently operated subsidiary of Bayer AG, today announced positive top-line results...
by admin | Jun 29, 2023 | News & Opinions
By Kyoto University Kyoto, Japan — Animal experimentation may not be a thing of the past just yet, but work on human iPS cell technology may someday grant emancipation for lab mice and other species. Renal proximal tubules play a major role in our kidneys’...
by admin | Jun 27, 2023 | News & Opinions
By Paul McClure – New Atlas Researchers have developed a noninvasive method of delivering CRISPR gene editing technology to the brains of mice, knocking out a gene that causes anxiety Anxiety affects many people, and for some, medication doesn’t help....
by admin | Jun 26, 2023 | News & Opinions
Photo of iPSCs-derived Motor neurons derived from an ALS patient. Credit: Morimoto et al/Cell Stem Cell By Cell Press – SciTechDaily Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease is a lethal neurological disorder that progressively...
by admin | Jun 22, 2023 | News & Opinions
By David Cyranoski – New York Times Science is known for rigorous self-policing by the research community, yet it can seem that scientific fraud is rampant. Why do frauds think they can get away with it? The story of Hwang Woo-suk, a South Korean scientist who...
